IDH1 and neoplasm: While this mutation is responsible for approximately 90% of all IDH1 mutant tumours, our study may have underestimated the actual number of IDH1-positive tumours by as much as 10%.[4] Finally, biopsy can result in under sampling and 12 patients in our study underwent biopsy-only prior to treatment.